HIGHLIGHTS
- who: Reference Member State (R et al. from the (UNIVERSITY) have published the article: Unrealized potential of in Europe during COVID-19 and beyond: physician's perspective, in the Journal: (JOURNAL)
- what: The aim of the pharmaceutical legislation in the EU is to protect uncontrolled movement of medicinal products and to safeguard public health.
- how: (EC) No 726/2004) + 1 year data exclusivity for a new therapeutic indication for a well-established substance provided that significant pre-clinical or clinical studies were carried out in relation to the new indication (Art. 10(5 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.